SCHEMBL28059433

SCHEMBL28059433

COc1cc(C(N)=O)c(C)nc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NNMT P40261 2/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ GAA P10253 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ ROCK2 O75116 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ P2RX3 P56373 1/20 0.39
▸ P2RX2 Q9UBL9 1/20 0.39
▸ MKNK1 Q9BUB5 1/20 0.38
▸ MKNK2 Q9HBH9 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ CDC7 O00311 1/20 0.38
▸ CCNE1 P24864 1/20 0.38
▸ CDK2 P24941 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4662906 0.83 NNMT (0.51) NNMTKDM4EGAAALDH1A1GLA
SCHEMBL2674736 0.80 KDM4E (0.49) NNMTKDM4EGAAALDH1A1GLA
SCHEMBL15525456 0.76 IRAK4 (0.51) NNMTKDM4ESMN1; SMN2MKNK1MKNK2
SCHEMBL28628579 0.75 SMN1; SMN2 (0.62) NNMTKDM4EPOLBSMN1; SMN2L3MBTL1
SCHEMBL15648561 0.74 KDM4E (0.44) NNMTKDM4EGAAALDH1A1GLA
SCHEMBL17371698 0.73 TDP1 (0.53) KDM4EALDH1A1HPGDPOLBL3MBTL1
SCHEMBL21198869 0.72 POLB (0.45) KDM4EGAAALDH1A1GLAHPGD
SCHEMBL3345488 0.72 NNMT (0.53) NNMTKDM4EGAAALDH1A1GLA
SCHEMBL28285146 0.71 CYP3A4 (0.61) KDM4EGAAALDH1A1GLAHPGD
SCHEMBL10222121 0.71 NNMT (0.51) NNMTKDM4EGAAALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103319408-B For the compound of prevention and therapy cardiovascular disorder RESVERLOGIX CORP. (CA) (CA) 2016-04-13 — — CN disclosed
Send feedback